IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Living RheumIL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
Living RheumUnderstanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
Early Arthritis Insights from the CATCH Cohort
Living RheumEarly Arthritis Insights from the CATCH Cohort
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living RheumSpot the Difference: Acute vs. Subacute Cutaneous Lupus
Key Advances in Rheumatology at CCR East 2026
Living RheumKey Advances in Rheumatology at CCR East 2026
- advertisement
- 5 questions
- 5 questions
- advertisement
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Medical Industry FeatureInsights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Early Referral in PMR Management and the Impact on Outcomes
Medical Industry FeatureEarly Referral in PMR Management and the Impact on Outcomes
Understanding Dual Inhibition of IL-17
Medical Industry FeatureUnderstanding Dual Inhibition of IL-17
- 05/08/2026
- 05/06/2026
- 05/04/2026
- 04/24/2026
- 04/22/2026
- 04/21/2026



























































